Incyte to Host EULAR Webcast and Conference Call on June 12
The schedules for the press release, webcast and conference call are as follows: -0-
-- EULAR Press Release: June 12, 2008 at 7:00 a.m. ET -- EULAR Webcast & Conference Call: June 12, 2008 at 8:30 a.m. ET -- The live listen only webcast with slides of the presentation can be accessed on Incyte's website: http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-Calendar -- Analysts and investors are also invited to participate in the conference call by calling the following toll free numbers:-0-
Domestic Dial In Number: 877-407-8037 International Dial In Number: 201-689-8037 Conference ID #: 286637
If you are unable to participate, a replay of the webcast will be available on Incyte's website and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
Incyte is a Wilmington, Delaware-based drug discovery and development company with a growing pipeline of oral compounds to treat oncology, inflammation, diabetes and HIV. For additional information on Incyte visit the Company's web site at www.incyte.com.
Pamela M. Murphy
Investor Relations & Corporate Communications
Posted: June 2008